Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(6)
•••
rejaj
X
View Profile
View Bullboard History
Post by
rejaj
on Mar 28, 2024 11:33am
One conference call - much to discuss
The comments related to Labs Q4 and Full Year results have been very interesting. The full spectrum of reactions and emotions are all there as would be expected given the details provided in the
...more
(270)
•••
alleyesonme
X
View Profile
View Bullboard History
Post by
alleyesonme
on Mar 28, 2024 11:29am
Additional revenue sources 2024.
Earnings call pidduck said they signed multiple B2B contracts which could lead to 10m annualized with more in the works....dronabinol already at 1.5m this year...this potentially adds 16m annually
...more
(97)
•••
subaru1
X
View Profile
View Bullboard History
Comment by
subaru1
on Mar 28, 2024 11:07am
RE:RE:RE:RE:If you haven’t listened to Earnings call…
Totally agree with you and the stock price is reflecting exactly it. First qrt should show around 11 millions of revenue and Ebitda around (500k) if there is a change in tht taxes we will become EPS
...more
(496)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on Mar 28, 2024 9:57am
RE:RE:RE:RE:RE:If you haven’t listened to Earnings call…
when did anyone say anything about a RS did i miss something????? also $.09 seems to be the new $.07..... hope this dosent go on for as long as the $.07 lasted
(602)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Mar 28, 2024 9:55am
News from DEA today or tomorrow?
U.S. Federal government is open on Friday, including DEA. I can understand the 'rush' on this earings announcment and CC.
(1871)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Mar 28, 2024 9:52am
RE:Potential benefit of Tax cuts
A cut to the excise tax would flow100% to the bottom line. April 16 federal budget better have some good news otherwise feds will bankrupt the industry and return it to the black market.
(602)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Mar 28, 2024 9:50am
For North America, where LABS is located with their
'traditional' global pharm partner, the REAL value of LABS is unlocked by DEA rescheduling, opening the path for pharmaceuticals to be commercialized after FDA approval. Management
...more
(824)
•••
Danno13
X
View Profile
View Bullboard History
Post by
Danno13
on Mar 28, 2024 9:48am
Potential benefit of Tax cuts
Financial Implications: Let’s consider Village Farms as a case study. The shift to a 10% excise tax rate could trim its annual excise tax bill from C$29.2 million to just
...more
(16)
•••
Lvlchange
X
View Profile
View Bullboard History
Comment by
Lvlchange
on Mar 28, 2024 9:43am
RE:RE:RE:RE:RE:If you haven’t listened to Earnings call…
Agree.
(116)
•••
Starkicker
X
View Profile
View Bullboard History
Comment by
Starkicker
on Mar 28, 2024 9:38am
RE:RE:RE:RE:If you haven’t listened to Earnings call…
The moment I hear any mention of RS I am gone.
(30)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on Mar 28, 2024 7:47am
RE:RE:RE:If you haven’t listened to Earnings call…
Exactly this. And I hope now we can move away from the 52 strong and late stage clinical trial nonsense as they now have put a bullet square in the head of that. That said, the transcript was
...more
(466)
•••
1hot-techwoman
X
View Profile
View Bullboard History
Post by
1hot-techwoman
on Mar 28, 2024 7:36am
Take Reform could boost MJ stocks by 300%! Come Apr 16th :)
https://markets.businessinsider.com/news/stocks/canadian-cannabis-companies-could-see-valuations-soar-by-up-to-300-with-tax-reform-new-report-shows-1033197003
(466)
•••
1hot-techwoman
X
View Profile
View Bullboard History
Post by
1hot-techwoman
on Mar 28, 2024 7:28am
Correction :) Book Value is $0.20 as per TD Bank :)
Medipharm Labs Corp does not pay a dividend. Beta 1.09 EPS $-0.05 Book
...more
(466)
•••
1hot-techwoman
X
View Profile
View Bullboard History
Post by
1hot-techwoman
on Mar 28, 2024 7:27am
Current Book Value is $0.10 as per TD Bank !!! :)
Medipharm Labs Corp does not pay a dividend. Beta 1.09 EPS $-0.05 Book
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada